Stay updated on BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.5 to v3.6.6, indicating a small maintenance update to the page metadata.
    Difference
    0.0%
    Check dated 2026-08-29T22:04:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new revision tag v3.6.5 appears, replacing the previous v3.6.4, indicating the study record has been updated to a newer version.
    Difference
    0.0%
    Check dated 2026-08-08T20:50:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a revised revision stamp: Revision: v3.6.4, replacing the previous version. This signals a small platform update to the page rendering rather than any substantive changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T12:37:09.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, indicating a new version of the study page.
    Difference
    0.0%
    Check dated 2026-07-04T04:20:53.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page's revision line now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-27T02:38:09.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The page now includes a recruitment status update indicating the study is no longer enrolling participants. It also introduces several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and notes the Revision: v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T14:47:27.000Z thumbnail image

Stay in the know with updates to BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.